Abramson Cancer Center

Research Expertise
My primary research focus has been on pediatric cancer drug development, specifically early phase clinical trails and clinical pharmacologic studies. Until 2008 I served as Chair of the Children's Oncology Group (COG) Developmental Therapeutics Programs and Principal Investigator of the COG Phase 1 Consortium, and in 2010 became Chair-elect of the Children’s Oncology Group. Prior to becoming the Director of the Office for Clinical and Translational Research at CHOP, I was the Program Director of the General Clinical Research Center (GCRC) and Principal Investigator of its NICHD funded Pediatric Pharmacology Research Unit (PPRU). My laboratory focuses on the clinical pharmacology of new drugs for childhood cancer using an integrated approach that incorporates preclinical studies in both in vitro and animal models, and clinical trials with clinical pharmacokinetic-pharmacodynamic-pharmacogenetic studies in pediatric patients. As Director of the Office for Clinical and Translational Research at CHOP, I work with clinical and translational investigators in identifying scientific opportunities and in forging productive collaborations throughout CHOP and the University of Pennsylvania.

Residency
Pediatrics, Children’s Hospital of Philadelphia

Fellowship
Pediatric Hematology/Oncology, Pediatric Oncology, National Cancer Institute

Board Certifications
American Academy of Pediatrics, American Academic of Pediatric Hematology Oncology, American Board of Clinical Pharmacology

Publications
Click here to see my publications

Researcher/Clinician:
Peter Adamson
Colket Translational Research Building
10060, 3501 Civic Center Blvd
Philadelphia, PA 19104-4318

Office Phone: 215-590-6359
Fax: 215-590-7544